Bifidobacterium breve M-16V (Bifidobacterium breve M-16V) - conditioning, skin protectant

INCI Name

Bifidobacterium brev...

Functions

2 Roles

Sustainability

8/10

What It Does

Bifidobacterium breve M-16V is a specific probiotic strain originally isolated from infant intestinal flora, developed by Morinaga Milk Industry Co., Ltd. in Japan. In cosmetic formulations, this lysate or ferment is used to support the skin microbiome, reinforce the skin barrier, and modulate cutaneous immune responses, making it particularly relevant for sensitive and atopic-prone skin. Formulators select this specific strain for its well-documented clinical history in infant health research, lending credibility to its use in gentle, microbiome-friendly skincare products.

Improves slip and manageability

Reduces static and frizz

Adds shine and smoothness

Protects from mechanical damage

Technical Properties

Ionic Charge

nonionic

Molecular charge type

Viscosity Effect

neutral

Impact on formula thickness

Foaming Ability

none

Lather generation

Ingredient Compatibility

Known Interactions

POTASSIUM SORBATEIncompatibleDegradation

Potassium Sorbate is an antimicrobial preservative that will kill probiotic organisms. Never use antimicrobial preservatives in probiotic formulations.

SODIUM BENZOATEIncompatibleDegradation

Sodium Benzoate is an antimicrobial preservative that will kill probiotic organisms. Never use antimicrobial preservatives in probiotic formulations.

CITRIC ACIDUse CautionDegradation

High concentrations of Citric Acid (pH < 3.5) can kill acid-sensitive probiotic strains (Lactobacillus, Bifidobacterium) during shelf life. Use acid-resistant strains or enteric coating if combining.

Compatibility analysis powered by OpenMix — open-source formulation science